의약품 부형제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global pharmaceutical excipients market size is expected to reach USD 26.36 Billion in 2034 from USD 13.52 Billion in 2025, growing at a CAGR of 7.7 during 2026-2034.This market is expanding steadily due to increasing pharmaceutical production and growing demand for high-quality drug formulations worldwide. Pharmaceutical excipients are inactive ingredients that enhance drug stability, improve bioavailability, support controlled release, and facilitate efficient manufacturing processes. Rising prevalence of chronic diseases, expanding generic drug production, and continuous innovation in drug delivery technologies are driving widespread adoption across the pharmaceutical industry.

The growing development of biologics, specialty medicines, and personalized therapies is significantly contributing to market growth. Pharmaceutical manufacturers are investing in multifunctional excipients that improve formulation performance while ensuring regulatory compliance and patient safety. Increasing research and development activities, expanding healthcare infrastructure, and rising demand for oral, injectable, and topical drug formulations further strengthen industry expansion. Technological advancements in excipient manufacturing continue improving product quality and consistency.

Future prospects remain highly encouraging as advanced drug delivery systems, biologic therapies, and precision medicine continue gaining momentum. Manufacturers are expected to focus on innovative excipient formulations that enhance therapeutic effectiveness and support complex pharmaceutical products. Growing investments in pharmaceutical research, expanding production capacities, and stronger regulatory emphasis on formulation quality will create significant long-term opportunities for excipient suppliers across global healthcare markets.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Organic Chemicals(Carbohydrates, Petrochemicals, Oleochemicals, Proteins, Other Organic Chemicals)
• Inorganic Chemicals(Halites, Metal Oxides, Silicates, Other Inorganic Chemicals)

By Functionality

• Fillers & Diluents
• Binders
• Suspension and Viscosity Agents
• Coatings(Film Coatings, Enteric Coatings)
• Flavoring Agents
• Disintegrants
• Colorants
• Preservatives
• Other Functionalities

By Formulation

• Oral Solid Dosage Forms
• Parenteral Formulations
• Topical & Transdermal
• Pulmonary/Inhalation
• Ophthalmic
• Others(Sublingual, Buccal, etc.)

By Source

• Plant-based
• Animal-based
• Synthetic
• Mineral-based
• Marine-based

COMPANIES PROFILED

• BASF SE, Ashland Global Holdings Inc., DuPont de Nemours Inc., Roquette Freres SA, Evonik Industries AG, Archer Daniels Midland Co., Kerry Group plc, The Lubrizol Corporation, Air Liquide SA, Croda International plc, Innophos Holdings Inc., Colorcon Inc., DFE Pharma GmbH & Co. KG, JRS Pharma GmbH & Co. KG, Eastman Chemical Company, International Flavors & Fragrances Inc., Merck KGaA, Dow Inc., Gattefosse SA, Shin-Etsu Chemical Co. Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Organic Chemicals(Carbohydrates, Petrochemicals, Oleochemicals, Proteins, Other Organic Chemicals) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Inorganic Chemicals(Halites, Metal Oxides, Silicates, Other Inorganic Chemicals) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Functionality
• 5.2. Fillers & Diluents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Binders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Suspension and Viscosity Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Coatings(Film Coatings, Enteric Coatings) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Flavoring Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Disintegrants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Colorants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Preservatives Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Other Functionalities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: BY FORMULATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Formulation
• 6.2. Oral Solid Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Parenteral Formulations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical & Transdermal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Pulmonary/Inhalation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Ophthalmic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others(Sublingual, Buccal, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: BY SOURCE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Source
• 7.2. Plant-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Animal-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Synthetic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Mineral-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Marine-based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Functionality
  • 8.2.3 By Formulation
  • 8.2.4 By Source
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Functionality
  • 8.3.3 By Formulation
  • 8.3.4 By Source
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Functionality
  • 8.4.3 By Formulation
  • 8.4.4 By Source
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Functionality
  • 8.5.3 By Formulation
  • 8.5.4 By Source
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Functionality
  • 8.6.3 By Formulation
  • 8.6.4 By Source
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL EXCIPIENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BASF SE
  • 10.2.2 Ashland Global Holdings Inc
  • 10.2.3 DuPont De Nemours Inc
  • 10.2.4 Roquette Freres SA
  • 10.2.5 Evonik Industries AG
  • 10.2.6 Archer Daniels Midland Co
  • 10.2.7 Kerry Group Plc
  • 10.2.8 The Lubrizol Corporation
  • 10.2.9 Air Liquide SA
  • 10.2.10 Croda International Plc
  • 10.2.11 Innophos Holdings Inc
  • 10.2.12 Colorcon Inc
  • 10.2.13 DFE Pharma GmbH & Co. KG
  • 10.2.14 JRS Pharma GmbH & Co. KG
  • 10.2.15 Eastman Chemical Company
  • 10.2.16 International Flavors & Fragrances Inc
  • 10.2.17 Merck KGaA
  • 10.2.18 Dow Inc
  • 10.2.19 Gattefoss e SA
  • 10.2.20 Shin-Etsu Chemical Co. Ltd